Failure to Reevaluate PASRR After Psychiatric Changes
Summary
The facility failed to ensure residents with new psychiatric diagnoses or significant changes in psychiatric status were reevaluated for a level II PASRR screening. The facility’s policy stated that residents with increased behavioral, psychiatric, or mood-related symptoms, or a newly evident serious mental disorder, intellectual disability, or related condition, were to be referred promptly for a level II resident review. In the sample reviewed, four residents had records showing psychiatric changes or diagnoses that were not followed by documentation of a new PASRR review. R4 had a prior level I PASRR screening that found only Anxiety Disorder and no need for a level II evaluation, but the screening also stated that if changes occurred, a new screen must be submitted. R4’s current record showed a diagnosis of Unspecified Dementia with severe Psychotic Disturbance and a start date for Risperidone for dementia with psychosis. The Regional Nurse Consultant confirmed R4 did not have a level II PASRR screening and that the new psych status and antipsychotic use represented a change that should have triggered a new screen. R57’s prior level I PASRR screening identified Anxiety Disorder only, but the current record showed a diagnosis of Delusional Disorder and later initiation of Abilify. Staff confirmed R57 had hallucinations and increased behaviors after a room move, and the DON confirmed a new PASRR screening should have been completed when the new psych diagnosis and antipsychotic medication were added. R7 had a prior level II PASRR from 2023 for schizophrenia, but after admission the record showed psychosis and orders for Aripiprazole and Seroquel for schizophrenia without documentation of a new PASRR review; the Social Services Director and Administrator confirmed the facility did not initiate a new level II PASRR. R17’s record showed diagnoses including dementia with psychotic disturbance, mood disturbance, anxiety, and depression, with orders for Clonazepam and Seroquel, and the Regional Nurse Consultant stated the target behaviors for Seroquel were not appropriate and that a new PASRR should have been initiated on admission.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.